Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Polycystic Ovary Syndrome × semaglutide × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 6 Letrozole 3 Pharmaceutical Preparations 2 semaglutide 1 salicylsalicylic acid 1 mirabegron 1 drospirenone and ethinyl estradiol combination 1 Vitamins 1 Thioctic Acid 1 Progesterone 1 Itraconazole 1 Inositol 1 Hydroquinones 1 Gonadotropin-Releasing Hormone 1 Flutamide 1 Flour 1 Fish Oils 1 Docosahexaenoic Acids 1 Clomiphene 1 Ascorbic Acid 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06222437 2024-03-27

Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy

Methodist Health System

Phase 1 Not yet recruiting

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡